Nicolas C Issa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Nicolas C Issa

Showing results (21-30 of 49) with videos related to

Pageof 5

Sort By:

Open Forum Infectious Diseases|December 15, 2021

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell TransplantMichaël Desjardins, Xhoi Mitre, Amy C Sherman, et al.

Open Forum Infectious Diseases|March 27, 2023

<i>Babesia microti</i> Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone ProphylaxisNolan R Holbrook, Erik H Klontz, Gordon C Adams, et al.

Transplantation|May 15, 2014

Serologic response to hepatitis B vaccination among lung transplantation candidatesAlicia Galar, Brian A Engelson, David W Kubiak, et al.

Open Forum Infectious Diseases|December 10, 2021

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19Robert W Finberg, Madiha Ashraf, Boris Julg, et al.

Journal of Clinical Microbiology|December 16, 2011

Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemiaNicolas C Issa, Sophia Koo, Robert C Lynch, et al.

Blood Advances|June 7, 2018

Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantationMatthew P Cheng, Alisha Pandit, Joseph H Antin, et al.

Open Forum Infectious Diseases|March 4, 2015

Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung diseaseDriele Peixoto, Sarah P Hammond, Nicolas C Issa, et al.

Transplantation|July 14, 2012

A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysisSophia Koo, David W Kubiak, Nicolas C Issa, et al.

NEJM Evidence|January 27, 2026

Solriamfetol for Excessive Sleepiness in Early-Morning Shift Work DisorderKirsi-Marja Zitting, Katherine R Gilmore, Brandon J Lockyer, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2017

Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell TransplantationDaniel P Prestes, Esther Arbona, Alexandra Nevett-Fernandez, et al.

Pageof 5

Search research articles

Showing results (21-30 of 49) with videos related to

Sort By:

Pageof 5

Open Forum Infectious Diseases|December 15, 2021

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell TransplantMichaël Desjardins, Xhoi Mitre, Amy C Sherman, et al.

Open Forum Infectious Diseases|March 27, 2023

<i>Babesia microti</i> Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone ProphylaxisNolan R Holbrook, Erik H Klontz, Gordon C Adams, et al.

Transplantation|May 15, 2014

Serologic response to hepatitis B vaccination among lung transplantation candidatesAlicia Galar, Brian A Engelson, David W Kubiak, et al.

Open Forum Infectious Diseases|December 10, 2021

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19Robert W Finberg, Madiha Ashraf, Boris Julg, et al.

Journal of Clinical Microbiology|December 16, 2011

Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemiaNicolas C Issa, Sophia Koo, Robert C Lynch, et al.

Blood Advances|June 7, 2018

Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantationMatthew P Cheng, Alisha Pandit, Joseph H Antin, et al.

Open Forum Infectious Diseases|March 4, 2015

Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung diseaseDriele Peixoto, Sarah P Hammond, Nicolas C Issa, et al.

Transplantation|July 14, 2012

A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysisSophia Koo, David W Kubiak, Nicolas C Issa, et al.

NEJM Evidence|January 27, 2026

Solriamfetol for Excessive Sleepiness in Early-Morning Shift Work DisorderKirsi-Marja Zitting, Katherine R Gilmore, Brandon J Lockyer, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2017

Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell TransplantationDaniel P Prestes, Esther Arbona, Alexandra Nevett-Fernandez, et al.

Pageof 5